| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.6B | $12.8B | $12.1B | $11.6B | $11.6B | $2.9B | $2.9B | $2.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.0B | $2.1B | $1.6B | $1.3B | $1.8B | $0.4B | $0.5B | $0.4B |
| Net Income | $0.7B | $0.9B | $0.7B | $0.6B | $1.0B | $0.2B | $0.2B | $-0.1B |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $1.56 | $1.89 | $-0.90 |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $1.50 | $1.88 | $-0.90 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $17.5B | $17.3B | $16.9B | $16.9B | $17.1B | $17.0B | $17.3B | $19.1B |
| Current Assets | $4.1B | $3.7B | $3.1B | $3.2B | $3.2B | $3.1B | $3.7B | $8.4B |
| Cash & Equivalents | $0.7B | $0.8B | $0.4B | $0.2B | $0.5B | $0.3B | $1.1B | $0.3B |
| Total Liabilities | $16.3B | $15.2B | $14.2B | $14.7B | $14.8B | $14.1B | $13.8B | $14.1B |
| Current Liabilities | $3.1B | $3.0B | $2.6B | $2.6B | $2.4B | $2.5B | $2.4B | $4.9B |
| Stockholders' Equity | $-0.7B | $0.1B | $1.1B | $0.7B | $0.8B | $1.4B | $2.1B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B | $2.0B | $2.1B | $1.6B | $1.9B | $2.0B | $2.1B | $1.8B |
| Investing Cash Flow | $-0.7B | $-0.8B | $-0.8B | $-0.6B | $-0.8B | $-0.8B | $3.0B | $-1.0B |
| Capital Expenditures | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.7B | $0.8B | $1.0B |
| Financing Cash Flow | $-1.4B | $-0.8B | $-1.2B | $-1.1B | $-1.1B | $-1.8B | $-4.7B | $-0.6B |